Maria Alvarez

2.2k total citations
64 papers, 1.5k citations indexed

About

Maria Alvarez is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Maria Alvarez has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 39 papers in Hepatology and 15 papers in Infectious Diseases. Recurrent topics in Maria Alvarez's work include Hepatitis C virus research (37 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (28 papers). Maria Alvarez is often cited by papers focused on Hepatitis C virus research (37 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (28 papers). Maria Alvarez collaborates with scholars based in Canada, United States and Australia. Maria Alvarez's co-authors include Mel Krajden, Amanda Yu, Naveed Z. Janjua, Mark Tyndall, Jason Wong, Zahid A Butt, Rory O’Brien, Stanley Wong, Margot Kuo and Hasina Samji and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Maria Alvarez

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Alvarez Canada	23	1.1k	902	456	190	112	64	1.5k
Catherine Troisi United States	14	515 0.5×	382 0.4×	382 0.8×	118 0.6×	43 0.4×	31	892
Phillip Read Australia	23	853 0.8×	522 0.6×	481 1.1×	208 1.1×	138 1.2×	88	1.5k
Rania A. Tohme United States	24	932 0.9×	798 0.9×	275 0.6×	108 0.6×	123 1.1×	76	1.7k
Catherine G. Sutcliffe United States	25	892 0.8×	414 0.5×	925 2.0×	296 1.6×	147 1.3×	98	1.9k
Fortune Ncube United Kingdom	22	855 0.8×	460 0.5×	359 0.8×	78 0.4×	290 2.6×	54	1.3k
Noel Craine United Kingdom	19	650 0.6×	404 0.4×	350 0.8×	207 1.1×	288 2.6×	39	1.2k
Norah Palmateer United Kingdom	24	2.1k 1.9×	1.1k 1.3×	782 1.7×	177 0.9×	788 7.0×	54	2.3k
Henry Roberts United States	14	678 0.6×	476 0.5×	140 0.3×	220 1.2×	56 0.5×	27	1.0k
Frederic E. Shaw United States	17	509 0.5×	300 0.3×	219 0.5×	192 1.0×	113 1.0×	29	1.0k
Jennifer Lloyd United States	12	370 0.3×	154 0.2×	186 0.4×	138 0.7×	103 0.9×	35	912

Countries citing papers authored by Maria Alvarez

Since Specialization

Citations

This map shows the geographic impact of Maria Alvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Alvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Alvarez more than expected).

Fields of papers citing papers by Maria Alvarez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Alvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Alvarez. The network helps show where Maria Alvarez may publish in the future.

Co-authorship network of co-authors of Maria Alvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Alvarez. A scholar is included among the top collaborators of Maria Alvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Alvarez. Maria Alvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makuza, Jean Damascène, Dahn Jeong, Stanley Wong, et al.. (2024). Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study. The Lancet Regional Health - Americas. 36. 100826–100826. 2 indexed citations

Makuza, Jean Damascène, Dahn Jeong, Mawuena Binka, et al.. (2022). Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study. Viruses. 14(11). 2579–2579. 5 indexed citations

Darvishian, Maryam, Stanley Wong, Mawuena Binka, et al.. (2022). Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort. Frontiers in Oncology. 12. 983238–983238. 6 indexed citations

Janjua, Naveed Z., Stanley Wong, Dahn Jeong, et al.. (2021). Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. Journal of Hepatology. 75(5). 1049–1057. 38 indexed citations

Wilton, James, Mei Chong, Mohammad Ehsanul Karim, et al.. (2021). Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study. BMJ. 375. e066965–e066965. 17 indexed citations

Binka, Mawuena, Zahid A Butt, Geoffrey McKee, et al.. (2021). Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada. International Journal of Infectious Diseases. 106. 246–253. 5 indexed citations

Wilton, James, Stanley Wong, Amanda Yu, et al.. (2020). Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study. Open Forum Infectious Diseases. 7(3). ofaa055–ofaa055. 26 indexed citations

Janjua, Naveed Z., Stanley Wong, Maryam Darvishian, et al.. (2020). The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk. Journal of Viral Hepatitis. 27(8). 781–793. 37 indexed citations

Bartlett, Sofia, Michael Otterstatter, Jane A. Buxton, et al.. (2020). Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services. International Journal of Infectious Diseases. 100. 27–33. 4 indexed citations

10.

Salway, Travis, Zahid A Butt, Stanley Wong, et al.. (2020). A Computable Phenotype Model for Classification of Men Who Have Sex With Men Within a Large Linked Database of Laboratory, Surveillance, and Administrative Healthcare Records. Frontiers in Digital Health. 2. 547324–547324. 3 indexed citations

11.

Krajden, Mel, Darrel Cook, Stanley Wong, et al.. (2019). What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada. International Journal of Drug Policy. 72. 114–122. 16 indexed citations

12.

Janjua, Naveed Z., Maryam Darvishian, Stanley Wong, et al.. (2019). Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy. Hepatology Communications. 3(4). 478–492. 22 indexed citations

13.

Darvishian, Maryam, Stanley Wong, Mawuena Binka, et al.. (2019). Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies. Journal of Viral Hepatitis. 27(3). 243–260. 23 indexed citations

14.

Butt, Zahid A, Sunny Mak, Dionne Gesink, et al.. (2018). Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada. Journal of Viral Hepatitis. 26(3). 373–383. 3 indexed citations

15.

Darvishian, Maryam, Naveed Z. Janjua, Mei Chong, et al.. (2018). Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk. Journal of Viral Hepatitis. 25(12). 1481–1492. 8 indexed citations

16.

Rossi, Carmine, Zahid A Butt, Stanley Wong, et al.. (2018). Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort. Journal of Hepatology. 69(5). 1007–1014. 100 indexed citations

17.

Islam, Nazrul, Mel Krajden, Jean Shoveller, et al.. (2017). Hepatitis C cross-genotype immunity and implications for vaccine development. Scientific Reports. 7(1). 12326–12326. 12 indexed citations

18.

Janjua, Naveed Z., Margot Kuo, Mei Chong, et al.. (2016). Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants. PLoS ONE. 11(3). e0150176–e0150176. 56 indexed citations

19.

Janjua, Naveed Z., Margot Kuo, Amanda Yu, et al.. (2016). The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC). EBioMedicine. 12. 189–195. 86 indexed citations

20.

Kuo, Margot, Deborah Money, Maria Alvarez, et al.. (2014). Test Uptake and Case Detection of Syphilis, HIV, and Hepatitis C Among Women Undergoing Prenatal Screening in British Columbia, 2007 to 2011. Journal of Obstetrics and Gynaecology Canada. 36(6). 482–490. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact